<?xml version="1.0" encoding="UTF-8"?>
<p>Six-week-old adult female mice (
 <italic>n </italic>= 2 per group) were subcutaneously injected with 150 μL of formaldehyde-inactivated whole virus CVA4. After the female was pregnant, the booster comprised the same dose of the vaccine at a 2-week interval. After delivery, the 3-day-old pups were injected with 100 LD
 <sub>50</sub> of the homologous CVA4 YT226R strain or 100 LD
 <sub>50</sub> of heterologous CVA4 strains (LY124R/SDLY/CVA4/China/2014; H337/SDHZ/CVA4/China/2015; LC16114/SDLC/CVA4/China/2016) or 100 LD
 <sub>50</sub> of other EVs: CVA6 (WF057R/CVA6/China/2014), CVA16 (TA271/CVA16/China/2015) and EVA71 (SD004R/EVA71/China/2015). The body weights, clinical scores and survival rates of the neonatal mice were measured daily.
</p>
